FDA Cites Gordon Laboratories Over Supplier Evaluations, Other Violations

Drug Industry Daily
A A
Drug manufacturer Gordon Laboratories received a Form 483 from the FDA for labeling problems, written procedure issues and insufficient analyses of raw materials.

To View This Article:

Login

Subscribe To Drug Industry Daily